Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1975 Aug 21;43(2):191-8.
doi: 10.1007/BF00421024.

Effects and plasma levels of N-desmethyldiazepam after oral administration in normal volunteers

Clinical Trial

Effects and plasma levels of N-desmethyldiazepam after oral administration in normal volunteers

H H Dasberg. Psychopharmacologia. .

Abstract

In the course of a previous study on the pharmaco-kinetics and effects of diazepam in anxiety patients, it was hypothesized that the N-desmethyl derivative is a disturbing agent causing side effects. The present study served to test the validity of this assumption. Diazepam and N-desmethyl-diazepam, the latter as a separate drug, were orally administered to 6 subjects, each drug during 7 days, 15 mg daily in divided doses. Using a randomized, placebo controlled, double-blind design, subjective and observer ratings of a wide range of clinical effects were made. Plasma levels of the benzodiazepine compounds were determined by the G.L.C. method. Results showed that steady state plasma levels were reached on the 5th day; the N-desmethyldiazepam, considering its lower clearance rates, is a longer acting drug than diazepam; that both substances induce hypnosedative effects, mood changes, and somatic disturbances and facilitate sexual behaviour in normals; that desmethyldiazepam is a more effective hypnosedative and mood-lowering substance as compared to equal doses of diazepam. Further comparisons in anxiety patients are recommended in order to find out if the specific desmethyldiazepma effects are therapeutically favourable or disturbing.

PubMed Disclaimer

References

    1. Curr Ther Res Clin Exp. 1973 Mar;15(3):83-91 - PubMed
    1. Clin Pharmacol Ther. 1972 Sep-Oct;13(5):803-8 - PubMed
    1. Psychopharmacologia. 1974 Apr 8;36(2):123-31 - PubMed
    1. Clin Pharmacol Ther. 1974 Sep;16(3):479-84 - PubMed
    1. Clin Pharmacol Ther. 1974 Sep;16(3):485-9 - PubMed